Re: RVX Long Covid Trial
in response to
by
posted on
May 27, 2023 09:57AM
Buckeyes, to your comment re China the following was just published in Nature. The bolding is mine.
China’s data privacy laws deter researchers
China’s new data restrictions have strengthened privacy but are concerning researchers globally. “The signal has been very clear that China does not want its scientists to collaborate as freely as they used to with foreigners,” says sociologist Joy Zhang.
China’s largest academic database has partially suspended foreign access, and institutions that send, for example, clinical-trial data abroad must now undergo a security assessment. Unlike the European Union’s data protection regulation, the law has no exemption for scientists.
The Chinese government has also proposed adding CRISPR gene editing, crop breeding and photovoltaics techniques to its list of technologies whose export is prohibited or restricted.
Nature | 7 min read
I find the RVX lack of funding extremely strange given all of the significant shareholders that could be rallying their funds and funds of associates to get numerous trials apabetalone trials into action.
Why aren't the people at ORI, CTS China Fund, Efung Capital, Ken Dart at Eastern, NGN Capital and CD Ventures (Christoph Boehringer), all significant RVX shareholders, stepping up to the plate and helping out poor, old, failing Don? This is a mystery.
It is such a mystery that in the absense of any communication and honesty from Don I think I'm going to become a conspiracy theorist. :)
GLTA, long and frustrated............
Toinv